Additional Neurological Conditions

In large part because of the commonality of underlying pathologic processes, Neuren believes that a product which proves to be safe and effective in Rett syndrome, Fragile X syndrome, or TBI has good potential as a therapy in a wide range of other neurological disorders. Trofinetide and NNZ-2591 could be good candidates for other neurodevelopmental disorders such as Angelman Syndrome and idiopathic autism, or neurodegenerative disorders such as Parkinson’s disease and multiple sclerosis.